These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14963351)

  • 21. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Mess F; Böhle A; Feller AC
    Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical value of aneusomy of chromosomes in exfoliated urothelial cells to predict the recurrence of superficial bladder cancer after complete transurethral resection].
    Bao QB; Liu J; Sun HB; Su JH; Zhu JG; Lin JZ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):548-51. PubMed ID: 19567078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).
    Zhao J; Richter J; Wagner U; Roth B; Schraml P; Zellweger T; Ackermann D; Schmid U; Moch H; Mihatsch MJ; Gasser TC; Sauter G
    Cancer Res; 1999 Sep; 59(18):4658-61. PubMed ID: 10493521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?
    Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R
    BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features.
    Mazzucchelli R; Barbisan F; Stramazzotti D; Montironi R; Lopez-Beltran A; Scarpelli M
    Anal Quant Cytol Histol; 2005 Jun; 27(3):143-51. PubMed ID: 16121635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
    Panani AD; Roussos C
    Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
    Visscher DW; Wallis TL; Crissman JD
    Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma.
    Inoue T; Sato K; Tsuchiya N; Matsuura S; Iinuma M; Habuchi T; Kato T
    Urology; 2004 Sep; 64(3):617-21. PubMed ID: 15351620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder.
    Cheng J; Huang H; Pak J; Shapiro E; Sun TT; Cordon-Cardo C; Waldman FM; Wu XR
    Cancer Res; 2003 Jan; 63(1):179-85. PubMed ID: 12517796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer.
    Mahdy E; Yoshihiro S; Zech L; Wester K; Pan Y; Busch C; Döhner H; Kallioniemi O; Bergerheim U; Malmström PU
    Anticancer Res; 1999; 19(1A):7-12. PubMed ID: 10226518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular characteristics of bladder cancer in young patients.
    Linn JF; Sesterhenn I; Mostofi FK; Schoenberg M
    J Urol; 1998 May; 159(5):1493-6. PubMed ID: 9554340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive detection of aneuploid cells in laryngeal epithelial precursor lesions.
    Shani T; Primov-Fever A; Wolf M; Shalmon B; Amarglio N; Trakhtenbrot L; Hirshberg A
    Cancer Cytopathol; 2011 Aug; 119(4):235-46. PubMed ID: 21557514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copy number aberrations using multicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC).
    Matsuyama H; Ikemoto K; Eguchi S; Oga A; Kawauchi S; Yamamoto Y; Kawai Y; Matsumoto H; Hara T; Nagao K; Sakano S; Sasaki K
    BJU Int; 2014 Apr; 113(4):662-7. PubMed ID: 23890221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.
    Slovak ML; Tcheurekdjian L; Zhang FF; Murata-Collins JL
    Cancer Res; 2001 Feb; 61(3):831-6. PubMed ID: 11221864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
    J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial allelotype of carcinoma in situ of the human bladder.
    Rosin MP; Cairns P; Epstein JI; Schoenberg MP; Sidransky D
    Cancer Res; 1995 Nov; 55(22):5213-6. PubMed ID: 7585577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.